The EGFLAM gene helps your retina, the light sensing tissue at the back of the eye, form stable connections between cells that pass visual signals to the brain. This gene plays an important role in keeping those connections organized so vision can stay clear and coordinated. If the EGFLAM gene does not work properly, signal transfer in the retina may be disrupted, which can contribute to vision problems and some inherited eye conditions.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
EGFLAMGene function
What if the gene works
The EGFLAM gene helps make a protein in the retina, the light sensing tissue at the back of the eye. This protein supports connections between photoreceptor cells and nearby nerve cells, helping vision work smoothly.
Risk
What if the gene does not work
Variants in the EGFLAM gene are linked to inherited retinal disease that can affect central vision, color vision, and fine detail, sometimes extending to broader vision loss. Milder or more severe variants can influence onset and severity.
Treatment
What does that mean for your treatment
No EGFLAM-specific treatment or management approach is currently established for pathogenic variants in the EGFLAM gene. Care is guided by the person’s eye findings, and the EGFLAM gene is mainly being studied in inherited retinal disease research rather than used as a routine drug target.
Gene function
What if the gene works
Clear vision depends on precise communication between cells in the retina. The EGFLAM gene supports this handoff by helping light sensing cells connect with nearby nerve cells in an orderly way. In daily life, that helps the eye send visual information forward smoothly.
The EGFLAM gene helps photoreceptors, the retina's light sensing cells, pass signals to bipolar cells. This supports the first stage of normal vision, where light is turned into a message the brain can read.
Its protein helps line up the contact points between neighboring retinal cells. This keeps the signaling area organized at the ribbon synapse (a fast communication site in the eye).
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Research on how variants influence the EGFLAM gene's function shows that these DNA changes can alter the pikachurin protein's shape, stability, or amount, which may weaken how retinal cells connect and signal. Some variants are milder and only partly reduce protein activity, while more disruptive variants can greatly lower or stop it. In EGFLAM related retinal disease, this range in functional impact may shape how early vision changes begin and how marked they become.
How variants are linked to conditions
Variants in the EGFLAM gene do not yet have a broadly confirmed link to a specific health condition, and research on EGFLAM gene variants and health conditions is still evolving. If you have a confirmed EGFLAM-related finding, your doctor or genetic counselor can explain what it may mean for your health and family history.
A variant is not necessarily a diagnosis
DNA variants are a usual part of human biology, and they are common across the general population. Most of these variants do not directly affect health and instead reflect normal human diversity. For many genes, having a variant connected with a condition suggests a possible association rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the EGFLAM gene. If an EGFLAM change is found, overall risk usually depends most on the exact genetic change and family history, and a doctor or genetic counselor can help explain what that may mean.
Inheritance of EGFLAM variants
For families trying to understand how EGFLAM gene variants are inherited, there is not yet a broadly confirmed disease specific inheritance pattern that is accepted across human genetics, and this may become clearer as research develops. EGFLAM is located on an autosome, which means you inherit one copy of the EGFLAM gene from each parent. In general, autosomal genes can be passed to children of any sex by either parent.
What does my EGFLAM result mean for my family?
EGFLAM results linked to a recognized inherited eye condition are usually passed down in a recessive way. For families, this often means parents can be healthy carriers, brothers and sisters may also carry the variant or, in some cases, have the condition, and other close relatives may want to learn whether the result runs in the family. The exact meaning for relatives depends on the specific EGFLAM result and the condition involved.
Genetic information
Genetic testing
How you find out about variants
Finding changes in the EGFLAM gene usually starts with genetic testing for EGFLAM variants using a blood sample, saliva, or cheek swab. A lab reads the DNA sequence to look for variants and compares them with known findings. Results may identify a relevant variant, find no likely cause, or show a change whose meaning is still unclear.
When should I consider getting a genetic test?
Genetic testing may be worth considering if you or a close relative has an inherited eye condition, especially vision loss that starts early in life or a retinal condition. Changes in the EGFLAM gene have been linked to some rare inherited vision conditions, so testing can help show whether EGFLAM may be involved.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but how much they explain varies by the condition and the type of variant involved. Lifestyle, environment, age, and medical history, among other influences, all shape how the body functions over time. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence both how much benefit a medicine provides and how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the EGFLAM gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines work or how treatment is chosen. Questions about side effects, medication changes, or new symptoms are best discussed with your doctor or pharmacist.
History
The EGFLAM gene first drew broad scientific interest in 2008, when Japanese researchers described a retinal protein they named pikachurin after the Pokémon character Pikachu. The playful name reflected how quickly the research team moved from discovery to public attention, and it made this gene unusually memorable compared with many others. Initially understood only through visible traits, later recognized as tied to a specific gene, the finding helped place EGFLAM on the map in vision research. As gene naming systems became more standardized, pikachurin came to be referred to as the EGFLAM gene. From these first observations, research expanded steadily, especially in studies of inherited eye conditions.